Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TGFB induced factor homeobox 1 pseudogene 1 (TGIF1P1) is a pseudogene derived from the TGIF1 locus, classified among the non-coding homeobox pseudogenes in the human genome. Pseudogenes are remnants of genes that have lost the ability to encode proteins due to evolutionary mutations, deletions, or insertions. Unlike their parental genes, pseudogenes do not produce functional proteins and typically lack any direct biological or disease relevance. TGIF1P1 is annotated based on sequence similarity to TGIF1 but has not been implicated in any biological function, molecular mechanism, or pathology, nor does it serve as a therapeutic target or biomarker.
Not applicable. No mechanism of action, as TGIF1P1 does not produce a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TGFB induced factor homeobox 1 pseudogene 1 (TGIF1P1).